Form: Lyophilized powder
Purity: >99%
Tirzepatide is a dual agonist that targets both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, amplifying the effects of both incretin hormones. This dual action enhances insulin secretion, reduces glucagon levels, and improves glucose regulation more effectively than single-pathway agonists. Additionally, Tirzepatide influences metabolic signaling pathways to support energy balance and lipid metabolism, contributing to improved nutrient processing and storage.
TIRZEPATIDE 10 MG
Comprised of 39 amino acids, Tirzepatide, a synthetic analog of the gastric inhibitory polypeptide (GIP), stands as a comparatively large peptide that appears to exert physiological potential through targeting and binding to GIP and GLP-1 (glucagon-like peptide-1) receptors.
Through this possible binding mechanism, Tirzepatide may stimulate insulin release from pancreatic cells, potentially enhancing glucose metabolism. Notably, the long-term presentation of Tirzepatide has been reported by researchers to elicit an apparent increase in adiponectin levels.1 Scientific investigations have indicated that Tirzepatide may exhibit an array of actions, including possible suppression of appetite, reduction of circulating insulin levels, and possible improvement of insulin sensitivity.
